| 08/07/2026 4:28 PM | MORGAN STANLEY (895421) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 08/07/2026 4:32 PM | MORGAN STANLEY (895421) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 08/07/2026 10:07 AM | FMR LLC (315066) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 08/06/2026 9:48 AM | FMR LLC (315066) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 07/31/2026 9:47 AM | VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 07/30/2026 10:18 AM | BlackRock, Inc. (2012383) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 07/20/2026 3:40 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:22 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:25 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:26 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:28 PM | XOMA (791908) Filer | Form S-8 POS | |
Get the Latest News and Ratings for XOMAO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter.
|
| 07/20/2026 3:29 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:29 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:30 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:31 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:34 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:35 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:35 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:36 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/20/2026 3:16 PM | XOMA (791908) Filer | Form POS AM | |
| 07/20/2026 3:19 PM | XOMA (791908) Filer | Form S-8 POS | |
| 07/16/2026 4:00 PM | BIOTECHNOLOGY VALUE FUND L P (918923) Filed by XOMA (791908) Subject | Form SCHEDULE 13D/A | |
| 07/16/2026 4:02 PM | BIOTECHNOLOGY VALUE FUND II LP (1102444) Reporting BIOTECHNOLOGY VALUE FUND L P (918923) Reporting Biotechnology Value Trading Fund OS LP (1660683) Reporting BVF GP HOLDINGS LLC (1803809) Reporting BVF I GP LLC (1803805) Reporting BVF II GP LLC (1803806) Reporting BVF INC/IL (1056807) Reporting BVF PARTNERS L P/IL (1055947) Reporting BVF Partners OS Ltd. (1660684) Reporting LAMPERT MARK N (1233840) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/16/2026 7:31 AM | Nasdaq Stock Market LLC (1354457) Filed by XOMA (791908) Subject | Form 25-NSE | |
| 07/15/2026 9:39 AM | Nasdaq Stock Market LLC (1354457) Filed by XOMA (791908) Subject | Form 25-NSE | |
| 07/14/2026 8:45 PM | Franklin Heather L (1436658) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | Trigilio Jeffrey (1838671) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | PERRY MATTHEW D (1454337) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | Sitko Bradley (1959809) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | Hernday Natasha (1780547) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | Hughes Owen (1575933) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | WYSZOMIERSKI JACK L (1023225) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | Kosacz Barbara (1763316) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | LIMBER JOSEPH M (1216023) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:45 PM | Montano Maricel Perea (2076299) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 8:10 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/12/2026 4:22 PM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/12/2026 4:24 PM | XOMA (791908) Filer | Form DEFA14A | |
| 06/10/2026 4:19 PM | XOMA (791908) Filer | Form DEFM14A | |
| 05/26/2026 5:07 PM | Kosacz Barbara (1763316) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 5:07 PM | Franklin Heather L (1436658) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
The end may be near for these iconic stocks (Ad) Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge.
Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks.
Stream his free presentation to get every buy and sell recommendation with no membership or credit card required. Watch Marc Chaikin's free presentation and get his full buy-and-sell list today |
| 05/26/2026 5:08 PM | PERRY MATTHEW D (1454337) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 5:08 PM | Hernday Natasha (1780547) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 5:08 PM | LIMBER JOSEPH M (1216023) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 5:08 PM | WYSZOMIERSKI JACK L (1023225) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 10:28 AM | XOMA (791908) Subject | Form 425 | |
| 05/22/2026 5:01 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 4:26 PM | BIOTECHNOLOGY VALUE FUND L P (918923) Filed by XOMA (791908) Subject | Form SCHEDULE 13D/A | |
| 05/18/2026 4:29 PM | BIOTECHNOLOGY VALUE FUND II LP (1102444) Reporting BIOTECHNOLOGY VALUE FUND L P (918923) Reporting Biotechnology Value Trading Fund OS LP (1660683) Reporting BVF GP HOLDINGS LLC (1803809) Reporting BVF I GP LLC (1803805) Reporting BVF II GP LLC (1803806) Reporting BVF INC/IL (1056807) Reporting BVF PARTNERS L P/IL (1055947) Reporting BVF Partners OS Ltd. (1660684) Reporting LAMPERT MARK N (1233840) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 8:11 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 8:13 AM | XOMA (791908) Filer | Form DEFA14A | |
| 05/15/2026 8:03 AM | Woodline Partners LP (1784547) Filed by XOMA (791908) Subject | Form SCHEDULE 13G | |
| 05/12/2026 3:06 PM | XOMA (791908) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/01/2026 8:15 PM | LIGAND PHARMACEUTICALS INC (886163) Filed by XOMA (791908) Subject | Form SCHEDULE 13D | |
| 04/30/2026 1:38 PM | VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by XOMA (791908) Subject | Form SCHEDULE 13G | |
| 04/29/2026 4:43 PM | BIOTECHNOLOGY VALUE FUND L P (918923) Filed by XOMA (791908) Subject | Form SCHEDULE 13D/A | |
| 04/27/2026 6:37 PM | LIGAND PHARMACEUTICALS INC (886163) Filer XOMA (791908) Filer | Form DEFA14A | |
| 04/27/2026 3:12 PM | BlackRock, Inc. (2012383) Filed by XOMA (791908) Subject | Form SCHEDULE 13G | |
| 04/27/2026 3:01 PM | XOMA (791908) Filer | Form 8-K/A | |
| 04/27/2026 7:16 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/27/2026 7:19 AM | XOMA (791908) Filer | Form DEFA14A | |
| 04/22/2026 3:30 PM | Sitko Bradley (1959809) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:30 PM | Hughes Owen (1575933) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:30 PM | Montano Maricel Perea (2076299) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:30 PM | Trigilio Jeffrey (1838671) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 5:13 PM | Trigilio Jeffrey (1838671) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/31/2026 3:30 PM | LIMBER JOSEPH M (1216023) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/30/2026 4:34 PM | XOMA (791908) Filer | Form DEFA14A | |
| 03/30/2026 4:35 PM | XOMA (791908) Filer | Form ARS | |
| 03/27/2026 1:14 PM | VANGUARD GROUP INC (102909) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 03/26/2026 3:30 PM | WYSZOMIERSKI JACK L (1023225) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 5:45 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/17/2026 3:38 PM | Hughes Owen (1575933) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 6:09 PM | Montano Maricel Perea (2076299) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 6:09 PM | Trigilio Jeffrey (1838671) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 6:09 PM | Sitko Bradley (1959809) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 9:05 AM | FMR LLC (315066) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 03/02/2026 5:04 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/12/2026 1:36 PM | MORGAN STANLEY (895421) Filed by XOMA (791908) Subject | Form SCHEDULE 13G/A | |
| 02/09/2026 3:19 PM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/30/2026 4:14 PM | Generation Bio Co. (1733294) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 01/15/2026 3:25 PM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/14/2026 3:30 PM | Trigilio Jeffrey (1838671) Reporting XOMA (791908) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 01/14/2026 3:35 PM | Trigilio Jeffrey (1838671) Reporting XOMA (791908) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 6:58 AM | Generation Bio Co. (1733294) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 01/12/2026 6:00 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/09/2026 3:05 PM | Generation Bio Co. (1733294) Subject XOMA (791908) Filed by | Form SC TO-T | |
| 12/15/2025 7:36 PM | Generation Bio Co. (1733294) Subject XOMA (791908) Filed by | Form SC TO-C | |
| 12/05/2025 8:15 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/21/2025 6:50 AM | LAVA Therapeutics NV (1840748) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 11/21/2025 7:03 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Ready to give options a try? Your first trade (Ticker included) -INSIDE (Ad) Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow. Send me my free guide |
| 11/13/2025 6:16 AM | LAVA Therapeutics NV (1840748) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 11/12/2025 6:46 AM | XOMA (791908) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/12/2025 6:46 AM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/17/2025 11:22 AM | LAVA Therapeutics NV (1840748) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 10/03/2025 4:24 PM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/03/2025 4:00 PM | XOMA (791908) Filer | Form 424B5 | |
| 10/03/2025 4:03 PM | XOMA (791908) Filer | Form 424B5 | |
| 10/02/2025 3:35 PM | LAVA Therapeutics NV (1840748) Subject XOMA (791908) Filed by | Form SC TO-T/A | |
| 09/26/2025 4:29 PM | XOMA (791908) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |